Previous close | 244.96 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 4,996 |
Market cap | 4.911B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 0.83 |
EPS (TTM) | 6.52 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Eli Lilly ( NYSE:LLY ) First Quarter 2024 Results Key Financial Results Revenue: US$8.77b (up 26% from 1Q 2023). Net...
The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the second quarter of 2024 of $1.30 per share on outstanding common stock.
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.